Applications of Ethyl 2-(4'-Hydroxyphenyl)-1,3-Oxazole-4-Carboxylate in Industrial Manufacturing

Ethyl 2-(4'-Hydroxyphenyl)-1,3-Oxazole-4-Carboxylate demonstrates significant value across several advanced fine chemical and specialty materials sectors. As an original manufacturer with years of technical experience, we supply this compound primarily for targeted applications based on its established properties and verified functional roles in precisely engineered formulations. Below, we outline specific industrial scenarios highlighting unique downstream uses.

1. Pharmaceutical Intermediate for Selective Estrogen Receptor Modulator (SERM) Synthesis

Manufacturers use this oxazole derivative as a key building block for synthesizing active pharmaceutical ingredients in the SERM category. Its phenolic and oxazole functionalities directly integrate in multi-step chemical syntheses, conferring controlled selectivity and affinity profiles crucial for endocrine therapies. Accurate charge-in rates and compliance with regulatory frameworks are essential during each batch operation, to ensure final APIs meet tight quality and impurity requirements set by drug authorities.

Industry compliance standards

• ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients
• European Pharmacopoeia (Ph. Eur.) monograph 2.2.46 (residual solvents)
• United States Pharmacopeia (USP) General Chapter <1086> Impurities in Drug Substances
• FDA Guidance on Process Validation

Typical usage ratio

• Applied at a molar ratio of 1.00 to 1.05 versus the nucleophilic coupling substrate, with actual batch input calibrated based on target API yield, impurity controls, and reaction scale (generally 2–12% by total batch mass, depending on multi-step synthesis route adjustments).

Downstream process integration

• Operators introduce the compound during the coupling or ring-forming phase, often under inert atmosphere, with further processing requiring sequential extraction, crystallization, and purification by chromatography or HPLC for high-purity SERM intermediate isolation.

Final product types

• Bulk SERM APIs for oncology and menopause therapies
• Oral tablet and capsule pharmaceutical formulations
• Research-grade active molecules for medicinal chemistry development

2. Fluorescent Label Synthesis for Biochemical Assay Reagents

In analytical chemistry and biomedical research, downstream manufacturers employ this compound as a precursor to oxazole-based fluorescent markers. The extended conjugated structure provides stable fluorescence and high extinction coefficients, needed for sensitive detection systems in immunoassays and cell imaging. Industrial producers adhere to precise process and purity controls to ensure reproducibility and safety of final labeled reagents used in regulated laboratory environments.

Industry compliance standards

• OECD Principles of Good Laboratory Practice (GLP)
• ISO 13485 Quality Management for Medical Devices (applicable to diagnostic reagents)
• EN ISO 14971 Risk Management for Medical Devices
• REACH Registration for Laboratory Chemicals

Typical usage ratio

• Loaded at 0.2–1.4% (w/w) relative to total fluorophore precursor mass; precise proportion determined by quantum yield requirements, detector sensitivity, and matrix compatibility in finished assay kits.

Downstream process integration

• Enters the synthetic chain for fluorophore construction, with subsequent activation and covalent conjugation onto biomolecules (e.g., antibodies, oligonucleotides) executed under mild conditions to maintain labeling efficiency and functional group integrity.

Final product types

• Custom-labeled antibody reagents
• Fluorescent probe kits for ELISA and immunohistochemistry
• Molecular beacon sets for nucleic acid hybridization assays

3. Intermediate in High-Performance Polyester and Polycarbonate Additive Synthesis

Polymer manufacturers leverage the phenolic oxazole carboxylate’s structure to introduce UV absorption and enhanced thermal stability into engineering plastics. By reacting it into specialty additives, the compound helps improve lifespan, color retention, and dimensional stability of polymers used in demanding technical and electrical applications. The formulation parameters are informed by the end-use regulatory context and additive loading is tailored to meet customers’ processing and certification needs.

Industry compliance standards

• RoHS Directive 2011/65/EU (restriction of hazardous substances in electrical applications)
• UL 94 Flammability Standards for Plastics
• ISO 1043 (Plastics — Symbols and abbreviations)
• EN 71-3:2019 (Safety of toys — Migration of certain elements, if for toy-grade polymers)

Typical usage ratio

• Dosage ranges from 0.1–0.8% by weight of base polymer; exact ratio determined by required UV-blocking or flame-retardant performance in final polymer specification, with tight compounding controls during blending.

Downstream process integration

• Compounded with polymer melt pre-polymers during reactive extrusion or solution-polycondensation stages; downstream includes filtration and pellet formation, with specialized QC on additive distribution and migration during secondary processing.

Final product types

• Halogen-free flame-retardant polycarbonates
• UV-resistant PET foils and films for electrical insulation
• High-clarity engineering plastics for electronics housings

4. Fine Chemical Intermediate for Photo-Stabilizer Manufacturing

Our customers in the specialty additive industry utilize the oxazole carboxylate to develop photo-stabilizer molecules capable of boosting the lightfastness and weathering resistance of coatings, inks, and paints. The compound’s scaffold supports the rapid construction of hindered phenol and benzoxazole derivatives, which extend product durability in outdoor and automotive applications. Dosing, process inclusion, and compliance monitoring match the stringency of downstream application fields.

Industry compliance standards

• ISO 9001:2015 (Quality management for chemical production)
• ASTM D4303 (Lightfastness standards for pigmentary systems)
• GHS/CLP Regulation (EC) No 1272/2008 (Classification and labeling of chemicals)
• General Motors GMW 14872 (Weathering Test Methods for Automotive Coatings)

Typical usage ratio

• Formulators charge 0.3–2.0% by weight, calibrated to pigment load and substrate reactivity; adjustment made per exposure data and end-market application (building paints require upper range, ink-jet inks use lower).

Downstream process integration

• Introduced at early-stage additive synthesis, followed by functionalization with alkyl chains or aryl groups for solubility balance; final stabilizer is incorporated into coating batches during pre-mix or let-down stages for controlled light stabilization performance.

Final product types

• Exterior architectural coatings
• Automotive refinish paints
• UV-resistant industrial inks and primers

5. Precursor in the Synthesis of Analytical Reference Compounds for Drug Metabolism Studies

Analytical laboratories require structurally defined phenol-oxazole standards to calibrate and validate LC-MS/MS and NMR-based assays in pharmaceutical metabolism and toxicology. We supply this compound as a precursor for downstream synthesis of labeled references that enable quantitative measurement of drug metabolites and degradation byproducts, crucial for regulatory submission pipelines in new drug development.

Industry compliance standards

• USP General Chapter <621> Chromatography
• ISO/IEC 17025:2017 (General requirements for the competence of testing and calibration laboratories)
• FDA Bioanalytical Method Validation Guidance
• OECD Test Guidelines for Chemicals, Section 4 (Metabolism and Pharmacokinetics)

Typical usage ratio

• Used at 10–40 mg scale per reference standard batch; adjustment based on required analytical sensitivity, isotope labeling demands, and final reference material purity certification.

Downstream process integration

• Compound typically enters as the initial core scaffold in multi-step organic synthesis; transformation includes labeling (e.g., 13C or D incorporation), protection/deprotection steps, and final chromatographic purification.

Final product types

• Certified drug metabolite standards for bioanalytical labs
• Custom-labeled reference compounds for drug safety studies
• Degradation product markers for regulatory compliance panels